gabexate has been researched along with foy 251 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuji, M; Fujisawa, T; Itoh, H; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S | 1 |
| Arnold, R; Beckh, K; Göke, B; Müller, R | 1 |
| Yonezawa, H | 1 |
| Bonn, R; Brindley, CJ; Chasseaud, LF; Cheng, KN; Hood, AJ; Irons, SR; Midgley, I; Proctor, P | 1 |
| Adachi, M; Kakizoe, Y; Kitamura, K; Ko, T; Maekawa, A; Miyoshi, T; Shiraishi, N; Tomita, K; Wakida, N | 1 |
| Chen, J; Guo, H; Huang, Y; Liu, C; Shan, W; Xiao, Z | 1 |
6 other study(ies) available for gabexate and foy 251
| Article | Year |
|---|---|
Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Esters; Gabexate; Guanidines; Male; Organ Size; Pancreas; Pancreatitis; Proglumide; Rats; Rats, Inbred Strains; Secretin; Trypsin Inhibitors | 1990 |
Elimination of the low-molecular weight proteinase inhibitor camostate (FOY 305) and its degradation products by the rat liver.
Topics: Administration, Oral; Animals; Benzoates; Biotransformation; Esters; Female; Gabexate; Guanidines; In Vitro Techniques; Liver; Perfusion; Protease Inhibitors; Rats; Rats, Inbred Strains | 1987 |
Discrepancy between the potency of various trypsin inhibitors to inhibit trypsin activity and the potency to release biologically active cholecystokinin-pancreozymin.
Topics: Animals; Benzamidines; Cholecystokinin; Duodenum; Esters; Gabexate; Guanidines; Male; Pancreas; Rats; Rats, Inbred Strains; Stimulation, Chemical; Trypsin Inhibitors | 1984 |
Metabolic fate of 14C-camostat mesylate in man, rat and dog after intravenous administration.
Topics: Adult; Animals; Benzoates; Biotransformation; Blood Proteins; Carbon Radioisotopes; Dogs; Esters; Gabexate; Guanidines; Humans; Infusions, Intravenous; Male; Protease Inhibitors; Protein Binding; Rats; Rats, Sprague-Dawley; Tissue Distribution; Trypsin Inhibitors | 1994 |
Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Cells, Cultured; Esters; Gabexate; Guanidines; Hypertension; Kidney; Mice; Rats; Rats, Inbred Dahl; RNA, Small Interfering; Serine Endopeptidases; Serine Proteinase Inhibitors | 2009 |
Enhanced stability of oral insulin in targeted peptide ligand trimethyl chitosan nanoparticles against trypsin.
Topics: Administration, Oral; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Esters; Gabexate; Guanidines; Insulin; Intestinal Mucosa; Ligands; Nanoparticles; Polyglutamic Acid; Trypsin; Trypsin Inhibitors | 2015 |